Groundwater is a precious resource. It irrigates vast fields of vegetables in California and wheat in Kansas. It supplies water to a third of U.S. cities—and to 90 percent of people who aren’t on systems run by municipalities or private water... Read more »
Rachel King is CEO of GlycoMimetics (NASDAQ: GLYC), a Gaithersburg, MD-based drug developer, and the current chairwoman of the Biotechnology Industry Organization.
As a heavily regulated industry, biopharma’s interactions with politicians and policy makers are crucial, and BIO has grown... Read more »
A new San Diego biotech, led by former Trius Therapeutics CEO Jeff Stein, has raised over $30 million to advance new drugs to treat life-threatening invasive fungal infections, according to a recent regulatory filing.
Stein declined to discuss the financing by... Read more »
BIO attendees in San Diego, including this reporter, have one fewer item on their packed calendars. Biotech venture capitalist G. Steven Burrill, accused of fraud and wrongful termination by a former employee in a civil lawsuit, has cancelled his annual speech... Read more »
After spending almost $21 million last year to acquire NextBus, a Bay Area business that uses GPS data and wireless networks to predict when the next bus will arrive at any given bus stop, San Diego’s Cubic (NYSE: CUB)... Read more »
Summer is (gleefully for me) upon us. As the heat rises, innovators need fuel of all types—but perhaps most especially the beer type. At least that’s the way I see it. But not all beers fit the mold, so to speak,... Read more »
When mice chew through the insulation that protects a house’s wires, an electrician can repair the wires. People with multiple sclerosis, whose immune systems malfunction and attack the insulation of their own neural wires, don’t have that option. Helping them could... Read more »